文献速递妇科生殖医学

美国黑人与白人多囊卵巢综合征患者心血管代谢风险差异的系统综述与荟萃分析

Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2020-12-13

该研究系统检索并荟萃分析美国黑人与白人PCOS女性的心血管代谢风险差异,纳入11项高质量观察性研究(N=2851),发现黑人女性空腹胰岛素、HOMA-IR和收缩压更高,甘油三酯更低,而空腹血糖、血脂和舒张压无差异。未报告心血管事件和死亡率,异质性较高,提示需关注诊断与管理中的差异。

要点

  • 黑人PCOS女性空腹胰岛素和HOMA-IR显著高于白人女性。
  • 黑人PCOS女性收缩压较高,但甘油三酯较低。
  • 空腹血糖、总胆固醇、LDL-C、HDL-C和舒张压无显著差异。

核心结论

  • 黑人PCOS女性较白人女性表现出更不利的心血管代谢风险特征(胰岛素、HOMA-IR和收缩压升高,甘油三酯降低)。
  • 观察结果支持在黑人女性的诊断、监测和管理中考虑这些差异,并用于未来指南推荐。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Web of Science和Scopus至2020年3月5日(2020年9月11日确认)。
  • 纳入11项观察性研究,总样本N=2851(黑人652例,白人2199例),均为高质量(NOS评分≥8)。
  • 排除儿童(<17岁)、孕妇和绝经期女性(>50岁)。

主要发现

  • 空腹血糖无显著差异:平均差-0.61 mg/dL(95%CI -1.69至2.92),I2=62.5%。
  • 空腹胰岛素升高:平均差6.76 μIU/mL(95%CI 4.97至8.56),I2=59.0%。
  • HOMA-IR升高:平均差1.47(95%CI 0.86至2.08),I2=83.2%。
  • 收缩压升高:平均差3.32 mm Hg(95%CI 0.34至6.30),I2=52.0%。

临床怎么用

  • 对黑人PCOS女性应更关注胰岛素抵抗和收缩压的筛查与监测。
  • 甘油三酯较低不应排除其他代谢风险因素。
  • 诊断和管理中需考虑种族差异,但需结合个体情况。

局限性

  • 未报告心血管事件和死亡率,缺乏硬终点数据。
  • 研究间异质性较高(I2最高达83.2%)。
  • 无法区分生物学、环境、社会经济和医疗保健因素的相对贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We conducted a systematic review and meta-analysis to summarize and quantitatively pool evidence on cardiometabolic health disparities between Black and White women with polycystic ovary syndrome in the United States in response to the call for further delineation of these disparities in the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. DATA SOURCES: Databases of MEDLINE, Web of Science, and Scopus were searched initially through March 05, 2020, and confirmed on September 11, 2020. STUDY ELIGIBILITY CRITERIA: Observational studies documenting cardiometabolic risk profile (glucoregulatory, lipid profile, anthropometric, and blood pressure status) in Black and White women with polycystic ovary syndrome were included. Studies on children (<17 years old) and pregnant or menopausal-aged women (>50 years) were excluded. The primary outcome was fasting glucose. Furthermore, data on major cardiovascular events (stroke, coronary heart disease, heart failure) and mortality rate (cardiovascular death, total mortality) were evaluated. METHODS: Data were pooled by random-effects models and expressed as mean differences and 95% confidence intervals. Studies were weighted based on the inverse of the variance. Heterogeneity was evaluated by Cochran Q and I2 statistics. Study methodologic quality was assessed by the Newcastle-Ottawa scale. RESULTS: A total of 11 studies (N=2851 [652 Black and 2199 White]) evaluated cardiometabolic risk profile and all had high quality (Newcastle-Ottawa scale score of ≥8). No studies reported on cardiovascular events and mortality rate. Black women had comparable fasting glucose (-0.61 [-1.69 to 2.92] mg/dL; I2=62.5%), yet exhibited increased fasting insulin (6.76 [4.97-8.56] μIU/mL; I2=59.0%); homeostatic model assessment of insulin resistance (1.47 [0.86-2.08]; I2=83.2%); systolic blood pressure (3.32 [0.34-6.30] mm Hg; I2=52.0%); and decreased triglyceride (-32.56 [-54.69 to -10.42] mg/dL; I2=68.0%) compared with White women (all, P≤.03). Groups exhibited comparable total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and diastolic blood pressure (all, P≥.06). CONCLUSIONS: Black women with polycystic ovary syndrome have a greater tendency for an adverse cardiometabolic risk profile (increased insulin, homeostatic model assessment of insulin resistance, and systolic blood pressure) despite lower triglycerides than White women. Our observations support the consideration of these disparities for diagnostic, monitoring, and management practices in Black women and for future guideline recommendations. Given the heterogeneity among studies, future research should address the relative contributions of biologic, environmental, socioeconomic, and healthcare factors to the observed disparities. Furthermore, longitudinal research is required to address patient-pressing complications, including cardiovascular events and mortality rate in Black women with polycystic ovary syndrome as a high-risk yet understudied population.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Kazemi M, Kim JY, Parry SA, et al. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020. PMID: 33316275. doi:10.1016/j.ajog.2020.12.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。